Rockwell Medical, Inc. (the "Company") announced that the Company entered into a three-year product purchase agreement with Sanderling Renal Services, Inc. ("Sanderling"). Under the terms of this agreement, which includes supply and purchasing commitments and has the potential to generate millions of dollars in net sales for Rockwell Medical over the course of the contract, Rockwell Medical will be the preferred supplier of liquid and dry acid and bicarbonate hemodialysis concentrates to Sanderling's facilities located throughout California, Colorado, Nevada, Oklahoma, Tennessee, Illinois, and Utah. In addition to supplying hemodialysis concentrates and concentrates accessories, Rockwell Medical will also provide Sanderling with its DAMX45 Dry Acid Concentrate Mixer units to support Sanderling's preference to conveniently mix acid concentrate on-site.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.455 USD | -3.64% | +0.34% | -23.02% |
Apr. 17 | Rockwell Medical Continues to Expand Its Distribution Capabilities in Western United States | CI |
Apr. 04 | Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.02% | 42.73M | |
+25.83% | 661B | |
+26.86% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.64% | 231B | |
+5.36% | 200B | |
-8.92% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- RMTI Stock
- News Rockwell Medical, Inc.
- Rockwell Medical Enters into 3-Year Product Purchase Agreement with Sanderling Renal Services